EVOLUS, INC. Accounts Payable and Other Accrued Liabilities, Current
EVOLUS, INC. (EOLS) had Accounts Payable and Other Accrued Liabilities, Current of $1.56 million as of 2019-06-30, per its 10-Q filed 2019-08-12.
Discontinued › Notes › Payables and Accruals
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2019-08-12
- 2019-06-30: Accounts Payable and Other Accrued Liabilities, Current $1.56M.
- 2018-12-31: Accounts Payable and Other Accrued Liabilities, Current $210.00K.
| Period end | Accounts Payable and Other Accrued Liabilities, Current |
|---|---|
| 2019-06-30 | $1.56M 10-Q · filed 2019-08-12 |
| 2018-12-31 | $210.00K 10-Q · filed 2019-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |